About 1 result found for searched term "CD161" (0.124 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M28718 | CD161 | Epigenetic Reader Domain |
| NKR-P1A | ||
| CD161 (NKR-P1A) is a potent, selective and orally bioavailable bromodomain and extra-terminal (BET) bromodomain inhibitor with an IC50s of 28.2 nM and 7.2 nM for BRD4 BD1 and BRD4 BD2, respectively. CD161 has good anticancer activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
